Condition: CJD (Creutzfeldt Jakob Disease) · Prion Diseases · GSS · Sponsor: Massachusetts General Hospital
We are doing this research to identify biomarkers in individuals who are at-risk for familial prion disease. We hope to use these biomarkers to predict timing of disease onset in pre-symptomatic individuals and to guide the direction of future clinical trials.
This description comes directly from the study's public registry record.
Sophia D'Alessandro · 617-726-4026 · sedalessandro@mgh.harvard.edu
Alison McManus, DNP · ajmcmanus@mgh.harvard.edu
Always discuss trial participation with your own doctor first.
| Alzheimer's Clinical and Translational Research Unit | Charlestown, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05124392